NewAmsterdam Pharma
Founded 2019 · 112 employees on LinkedIn · 4 known investors
NewAmsterdam Pharma develops innovative therapies for cardiovascular disease and lipid-related conditions. The company aims to provide lipid-lowering treatments that help patients with cardiovascular risk manage their health.
Investors · 4
Competitors · 3
by search overlap
Seeking Alpha27 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Robinhood23 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Simply Wall St21 shared keywordsSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.
Companies competing with NewAmsterdam Pharma for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does NewAmsterdam Pharma do?
- NewAmsterdam Pharma develops innovative therapies for cardiovascular disease and lipid-related conditions. The company aims to provide lipid-lowering treatments that help patients with cardiovascular risk manage their health.
- Who are NewAmsterdam Pharma's investors?
- NewAmsterdam Pharma's investors include Bain Capital Life Sciences, EQT Life Sciences, Frazier Life Sciences, LSP (Life Sciences Partners).